tirzepatide macular degeneration Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Early worsening of diabetic retinopathy

[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Giron-Arango L., Perlas A

Tirzepatide handles the hunger

This helps reduce injection site irritation by neutralizing pH, making injections more comfortable

By stabilizing blood sugar and improving insulin sensitivity, Tirzepatide creates a healthier environment for the brain, protecting against damage

In contrast, Semaglutide maintains the GLP-1 (737) backbone, incorporates Aib8 and Arg34 modifications, and features a shorter C-18 lipid chain at Lys26, achieving weekly dosing while targeting only GLP-1 receptors 33

Nonsteroidal anti-inflammatory drugs (NSAIDs) such as high-dose aspirin or indomethacin have been reported to alter GH release in some contexts, though this is more pertinent to GH stimulation testing than chronic therapy